Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
Novanta (Nasdaq: NOVT), a technology partner specializing in medical and advanced technology equipment manufacturing, has announced its participation in the upcoming CJS Securities 25th Annual New Ideas for the New Year Investor Conference. The virtual event is scheduled for Tuesday, January 14, 2025. This conference represents an opportunity for Novanta's management to present their company's developments and strategies to investors.
Novanta (Nasdaq: NOVT), un partner tecnologico specializzato nella produzione di attrezzature mediche e tecnologie avanzate, ha annunciato la sua partecipazione alla prossima CJS Securities 25ª Conferenza Annuale delle Nuove Idee per il Nuovo Anno. L'evento virtuale è programmato per martedì 14 gennaio 2025. Questa conferenza rappresenta un'opportunità per il management di Novanta di presentare agli investitori gli sviluppi e le strategie dell'azienda.
Novanta (Nasdaq: NOVT), un socio tecnológico especializado en la fabricación de equipos médicos y tecnología avanzada, ha anunciado su participación en la próxima CJS Securities 25ª Conferencia Anual de Nuevas Ideas para el Nuevo Año. El evento virtual está programado para martes 14 de enero de 2025. Esta conferencia representa una oportunidad para que la dirección de Novanta presente los desarrollos y estrategias de la empresa a los inversores.
Novanta (Nasdaq: NOVT)는 의료 및 첨단 기술 장비 제조를 전문으로 하는 기술 파트너로, 다가오는 CJS Securities 제25회 새로운 해를 위한 새로운 아이디어 투자 컨퍼런스에 참여한다고 발표했습니다. 이 가상 이벤트는 2025년 1월 14일 화요일에 예정되어 있습니다. 이번 컨퍼런스는 Novanta 경영진이 투자자들에게 회사의 발전과 전략을 발표할 수 있는 기회를 제공합니다.
Novanta (Nasdaq: NOVT), un partenaire technologique spécialisé dans la fabrication d'équipements médicaux et de technologies avancées, a annoncé sa participation à la prochaine 25e Conférence Annuelle sur les Nouvelles Idées pour la Nouvelle Année de CJS Securities. L'événement virtuel est prévu pour le mardi 14 janvier 2025. Cette conférence représente une occasion pour la direction de Novanta de présenter aux investisseurs les développements et stratégies de l'entreprise.
Novanta (Nasdaq: NOVT), ein Technologiepartner, der sich auf die Herstellung von medizinischen und fortschrittlichen Technologiegeräten spezialisiert hat, hat seine Teilnahme an der kommenden CJS Securities 25. jährlichen Konferenz zu neuen Ideen für das neue Jahr angekündigt. Die virtuelle Veranstaltung ist für Dienstag, den 14. Januar 2025 geplant. Diese Konferenz bietet der Geschäftsleitung von Novanta die Gelegenheit, den Investoren die Entwicklungen und Strategien des Unternehmens vorzustellen.
- None.
- None.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”
More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241219004595/en/
Novanta Inc.
Investor Relations Contact:
Ray Nash
(781) 266-5137
Source: Novanta Inc.
FAQ
When is Novanta (NOVT) presenting at the CJS Securities New Ideas Conference 2025?
Is the CJS Securities Conference 2025 where NOVT is presenting a virtual event?
What type of companies does Novanta (NOVT) partner with?
Which stock exchange is Novanta (NOVT) listed on?
